Development and characterization of a long-acting nanoformulated abacavir prodrug
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and characterization of a long-acting nanoformulated abacavir prodrug
Authors
Keywords
-
Journal
Nanomedicine
Volume 11, Issue 15, Pages 1913-1927
Publisher
Future Medicine Ltd
Online
2016-07-26
DOI
10.2217/nnm-2016-0164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy
- (2016) Gang Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- Residual inflammation and viral reservoirs
- (2016) Marta Massanella et al. Current Opinion in HIV and AIDS
- N -myristoyltransferase 1 enhances human immunodeficiency virus replication through regulation of viral RNA expression level
- (2015) Hikaru Ohta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
- (2015) Pavan Puligujja et al. BIOMATERIALS
- Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis
- (2015) Olatunji O. Adetokunboh et al. BMC INFECTIOUS DISEASES
- Improving bioavailability and biodistribution of anti-HIV chemotherapy
- (2015) Giovanna Giacalone et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Development of albumin-based nanoparticles for the delivery of abacavir
- (2015) Barnabas Wilson et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Shape and size-dependent immune response to antigen-carrying nanoparticles
- (2015) Sunny Kumar et al. JOURNAL OF CONTROLLED RELEASE
- HIV reservoirs as obstacles and opportunities for an HIV cure
- (2015) Tae-Wook Chun et al. NATURE IMMUNOLOGY
- Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
- (2015) Mariluz Araínga et al. Retrovirology
- Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in Hiv-1 Treatment Naive Patients in France
- (2015) G Pialoux et al. VALUE IN HEALTH
- The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication
- (2015) Alessandro F. Fois et al. Current HIV/AIDS Reports
- Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats
- (2015) Prashant Kumar et al. PLoS One
- HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure
- (2014) Luke C. Swenson et al. AIDS
- Pharmacokinetics, Biodistribution, and Toxicity of Folic Acid-Coated Antiretroviral Nanoformulations
- (2014) Nagsen Gautam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance
- (2014) D. Guo et al. JOURNAL OF VIROLOGY
- Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention
- (2014) Jianing Meng et al. Nanomedicine
- Current prodrug strategies for improving oral absorption of nucleoside analogues
- (2014) Youxi Zhang et al. Asian Journal of Pharmaceutical Sciences
- Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections
- (2013) Pavan Puligujja et al. Nanomedicine-Nanotechnology Biology and Medicine
- Long-acting injectable antiretrovirals for HIV treatment and prevention
- (2013) William R. Spreen et al. Current Opinion in HIV and AIDS
- Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
- (2012) Prasanta K. Dash et al. AIDS
- Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention
- (2012) Tao Zhang et al. ANTIVIRAL RESEARCH
- Anti-HIV-1 nanotherapeutics: promises and challenges for the future
- (2012) Supriya Mahajan et al. International Journal of Nanomedicine
- Synthesis and Biological Evaluation of Fatty Acyl Ester Derivatives of (−)-2′,3′-Dideoxy-3′-thiacytidine
- (2012) Hitesh K. Agarwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection
- (2011) Vanessa Pirrone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation
- (2011) Ranjita Shegokar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
- (2011) Jonathan Z. Li JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
- (2010) Andries M. Bergman et al. INVESTIGATIONAL NEW DRUGS
- Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages
- (2010) Ari S. Nowacek et al. JOURNAL OF CONTROLLED RELEASE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophages Recognize Size and Shape of Their Targets
- (2010) Nishit Doshi et al. PLoS One
- NanoART synthesis, characterization, uptake, release and toxicology for human monocyte–macrophage drug delivery
- (2009) Ari S Nowacek et al. Nanomedicine
- Abacavir Hypersensitivity Reaction: an Update
- (2008) Christine A Hughes et al. ANNALS OF PHARMACOTHERAPY
- A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages
- (2008) W. Xia et al. BLOOD
- Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates
- (2008) C. P. Leamon et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started